Chemoinformaics analysis of heteroflavanone B
| Molecular Weight | 428.481 | nRot | 7 |
| Heavy Atom Molecular Weight | 400.257 | nRig | 19 |
| Exact Molecular Weight | 428.184 | nRing | 3 |
| Solubility: LogS | -4.808 | nHRing | 1 |
| Solubility: LogP | 5.131 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 64.3642 |
| nHD | 1 | BPOL | 37.6378 |
| QED | 0.643 |
| Synth | 3.324 |
| Natural Product Likeliness | 1.852 |
| NR-PPAR-gamma | 0.569 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.208 |
| Pgp-sub | 0.021 |
| HIA | 0.036 |
| CACO-2 | -4.678 |
| MDCK | 0.0000119 |
| BBB | 0.036 |
| PPB | 0.733258 |
| VDSS | 0.737 |
| FU | 0.260494 |
| CYP1A2-inh | 0.141 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.934 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.88 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.515 |
| CYP2d6-sub | 0.898 |
| CYP3a4-inh | 0.859 |
| CYP3a4-sub | 0.785 |
| CL | 10.786 |
| T12 | 0.158 |
| hERG | 0.046 |
| Ames | 0.041 |
| ROA | 0.799 |
| SkinSen | 0.502 |
| Carcinogencity | 0.072 |
| EI | 0.134 |
| Respiratory | 0.919 |
| NR-Aromatase | 0.724 |
| Antiviral | Yes |
| Prediction | 0.816674 |